RBM12B inhibitors belong to a specialized group of chemical agents that are tailored to target and hinder the function of RBM12B, which stands for RNA-binding motif protein 12B. RBM12B is a part of the larger family of RNA-binding proteins, which are critical components in the regulation of RNA metabolism including processes such as splicing, transport, localization, and turnover. These proteins, and by extension RBM12B, participate in the complex orchestration of post-transcriptional gene expression. RBM12B has a distinct role within the cell, binding to specific RNA sequences and influencing their fate within the cellular environment. The inhibitors designed to affect RBM12B aim to selectively bind to this protein and modify its RNA-binding ability, thereby influencing the intricate network of RNA-protein interactions.
The design and development of RBM12B inhibitors require a nuanced understanding of the protein's structure, the nature of its interaction with RNA, and the dynamic processes that govern these interactions. These inhibitors can be crafted from a variety of molecular frameworks, ranging from small organic compounds to larger biomolecules, each tailored to engage with RBM12B with high specificity. To ensure that these inhibitors precisely target RBM12B, extensive research is dedicated to deciphering the binding domains and the structural configurations that the protein adopts when interacting with RNA.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with RNA synthesis. Disruption of RNA synthesis can affect the binding of RNA-binding proteins like RBM12B. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II. By affecting RNA synthesis, it can indirectly impact RBM12B functions. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Binds to SF3b, a subcomplex of the spliceosome. By affecting splicing, it may influence RBM12B's roles related to RNA processing. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Targets the SF3b spliceosome complex. This can disrupt splicing activities, potentially affecting RBM12B. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II, affecting RNA synthesis and potentially the function of RBM12B. | ||||||
Herboxidiene | 142861-00-5 | sc-506378 | 1 mg | $1009.00 | ||
Affects spliceosome function. Alteration in splicing may impact RBM12B's role if it's involved in RNA splicing. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
A pre-mRNA splicing inhibitor that can influence RBM12B's potential role in splicing. | ||||||
Toyocamycin | 606-58-6 | sc-362812 | 10 mg | $138.00 | ||
An adenosine analog that interferes with RNA synthesis, possibly affecting the function of RNA-binding proteins like RBM12B. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Analog of adenosine, interferes with RNA synthesis, potentially affecting RNA-binding proteins like RBM12B. | ||||||